As of July 2024 Astellas Pharma has 1.82B shares outstanding, a decrease of -1.61% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 1.82B | -1.61% |
2022 | 1.85B | -0.40% |
2021 | 1.86B | -1.02% |
2020 | 1.88B | - |